Our Company

Breath Therapeutics is a biotechnology company focused on the development of aerosolized drugs to improve the treatment of rare and life-threatening pulmonary diseases.

Our founding and management team includes highly experienced executives and internationally renowned experts in drug aerosol and immunosuppression therapy.

With our lead program, BOSTON, we are developing the first therapy for treatment of Bronchiolitis Obliterans, which is a life-threatening lung disease without approved drug therapy.